There are 2789 resources available
1308P - Efficacy and safety of anti-PD-1 therapy plus anlotinib in previously treated advanced NSCLC
Presenter: Xin Lv
Session: ePoster Display
1309P - A multicenter phase I study of radium-223 (Ra-223) plus pembrolizumab in patients with stage IV non-small cell lung cancer (NSCLC)
Presenter: Martin Reck
Session: ePoster Display
1310P - Toripalimab combined with chemotherapy as second-line treatment of advanced non-small cell lung cancer (NSCLC): A single center retrospective study
Presenter: man Jiang
Session: ePoster Display
1311P - The role of inflammatory biomarkers in advanced non-small cell lung cancer patients treated with chemo-immunotherapy
Presenter: Emma Zattarin
Session: ePoster Display
372P - The prognostic value of liver metastases and how affects the applicability of the lung-molGPA in non-small cell lung cancer patients with brain metastases
Presenter: Joel Rafael Veas Rodriguez
Session: ePoster Display
373P - Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study
Presenter: Olav Yri
Session: ePoster Display
374P - A real-world application of aqueous humor and vitreous fluid for the diagnosis of vitreoretinal lymphoma and treatment monitoring
Presenter: Xiaoxiao Wang
Session: ePoster Display
375P - Clinical outcomes of targeting therapy with BRAF/MEK inhibitors in patients with BRAF V600-mutated brain tumors
Presenter: Marta Mejías Trueba
Session: ePoster Display
376P - Nucleolin and its prognostic value in pediatric patients with intracranial ependymoma: A systematic review and meta-analysis
Presenter: Jeremiah Wijaya
Session: ePoster Display
377P - Comparison of current guidelines and real-world evidence data for the treatment of glioblastoma across Europe
Presenter: Carrmen Escorial
Session: ePoster Display